Content overview: “K-Beauty Craze Made from Donated Human Skin Targets US Market”. A controversial beauty treatment that uses donated human skin from American cadavers is expanding into the United States after generating tens of millions of dollars globally. The product, part of the K-beauty wave, is marketed for its regenerative properties and has gained traction in Asia. Now, companies are seeking FDA approval and US distribution, raising ethical and regulatory questions.
The treatment involves processing human dermal tissue into injectable fillers or topical creams, a practice that some medical experts say is safe if properly screened, while others warn of potential risks and cultural taboos. With the global beauty industry increasingly blurring lines between cosmetics and medical procedures, this move could spark debate over sourcing, consent, and the commodification of human remains. The US market, valued at over $90 billion for beauty and personal care, presents a lucrative opportunity, but consumer acceptance remains uncertain. The full version stays on the original page, which this listing opens directly.